Literature DB >> 19902985

Oligomenorrhoea in exercising women: a polycystic ovarian syndrome phenotype or distinct entity?

Susan Awdishu1, Nancy I Williams, Sheila E Laredo, Mary Jane De Souza.   

Abstract

To date, the predominant mechanism underlying menstrual disturbances in exercising women supports an underlying energy deficiency-related aetiology, in which a failure to compensate dietary intake for the energy cost of exercise suppresses reproductive function. Increasing evidence demonstrates that energy deficiency plays a causal role in the induction of amenorrhoea in exercising women, and consistent with this mechanism are findings of glucoregulatory perturbations such as low triiodothyronine, reduced insulin secretion and elevated cortisol, growth hormone and ghrelin levels. The menstrual disturbance that may differ in its energetic characteristics and, perhaps in its androgenic and ovarian steroid environment, is oligomenorrhoea. We conducted a systematic review of the literature to begin to understand whether oligomenorrhoea in exercising women is a mild subclinical phenotype of polycystic ovarian syndrome (PCOS) in which exercise is conferring beneficial effects in protecting women from the classic PCOS phenotype, or whether oligomenorrhoea is part of the spectrum of menstrual disturbances caused by an energy deficiency that is often reported in exercising women with menstrual disturbances. We included observational, randomized controlled trials and cross-sectional studies that reported clinical, hormonal and metabolic profiles in exercising women with amenorrhoea or oligomenorrhoea and in women with PCOS. Previous studies examining the underlying mechanisms and consequences of exercise-associated menstrual disturbances have grouped exercising amenorrhoeic and oligomenorrhoeic women into a single group, and have relied primarily on self-reported menstrual history. Although scarce, the data available to date suggest that hyperandrogenism, such as that observed in PCOS, may likely be associated with oligomenorrhoea in exercising women, and may not always represent hypothalamic inhibition secondary to an energy deficiency. It is critical to closely examine the metabolic and endocrine status of women with menstrual disturbances because the treatment strategies for energy deficiency-related menstrual disturbances differ from that of disturbances traceable to hyperandrogenaemia. Further investigation is necessary to explore whether different endocrine aetiologies underly menstrual disturbances, particularly oligomenorrhoea, in physically active women.

Entities:  

Mesh:

Year:  2009        PMID: 19902985     DOI: 10.2165/11317910-000000000-00000

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  75 in total

1.  Reduced resting metabolic rate in athletes with menstrual disorders.

Authors:  M Lebenstedt; P Platte; K M Pirke
Journal:  Med Sci Sports Exerc       Date:  1999-09       Impact factor: 5.411

Review 2.  Obesity and androgens: facts and perspectives.

Authors:  Renato Pasquali
Journal:  Fertil Steril       Date:  2006-05       Impact factor: 7.329

3.  Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.

Authors:  Thomas M Barber; John A H Wass; Mark I McCarthy; Stephen Franks
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

4.  Secondary amenorrhoea in athletes.

Authors:  C B Feicht; T S Johnson; B J Martin; K E Sparkes; W W Wagner
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

Review 5.  Causes, evaluation, and management of athletic oligo-/amenorrhea.

Authors:  M M Shangold
Journal:  Med Clin North Am       Date:  1985-01       Impact factor: 5.456

6.  Induction of menstrual disorders by strenuous exercise in untrained women.

Authors:  B A Bullen; G S Skrinar; I Z Beitins; G von Mering; B A Turnbull; J W McArthur
Journal:  N Engl J Med       Date:  1985-05-23       Impact factor: 91.245

7.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Authors:  E Diamanti-Kandarakis; C R Kouli; A T Bergiele; F A Filandra; T C Tsianateli; G G Spina; E D Zapanti; M I Bartzis
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

8.  Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance.

Authors:  Anette Rickenlund; Kjell Carlström; Björn Ekblom; Torkel B Brismar; Bo von Schoultz; Angelica Lindén Hirschberg
Journal:  Fertil Steril       Date:  2003-04       Impact factor: 7.329

9.  High frequency of luteal phase deficiency and anovulation in recreational women runners: blunted elevation in follicle-stimulating hormone observed during luteal-follicular transition.

Authors:  M J De Souza; B E Miller; A B Loucks; A A Luciano; L S Pescatello; C G Campbell; B L Lasley
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

10.  Menstrual dysfunction in swimmers: a distinct entity.

Authors:  N W Constantini; M P Warren
Journal:  J Clin Endocrinol Metab       Date:  1995-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.